Advanced Therapies Week 2022 | The logistics of manufacturing allogeneic therapies on a large scale

Julia Tarasenko, MSc, Marken, Durham, NC, discusses changes that are needed in the supply chain to adapt to an increasing demand in allogeneic therapies. Pivoting to a one-to-many supply chain is crucial to successfully manufacture allogeneic therapies on a larger scale, as well as focusing on local suppliers and storage, especially in the light of the COVID-19 pandemic. She additionally highlights the need to increase biobanking capabilities as the industry shifts to allogeneic therapies. This interview took place at Advanced Therapies Week 2022.